1. Home
  2. AQN vs ABCL Comparison

AQN vs ABCL Comparison

Compare AQN & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Algonquin Power & Utilities Corp.

AQN

Algonquin Power & Utilities Corp.

HOLD

Current Price

$5.02

Market Cap

4.4B

Sector

Utilities

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$12.54

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQN
ABCL
Founded
1988
2012
Country
Canada
Canada
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.5B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
AQN
ABCL
Price
$5.02
$12.54
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$6.66
★ $8.40
AVG Volume (30 Days)
★ 4.0M
4.0M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
★ 4.22%
N/A
EPS Growth
N/A
★ 10.91
EPS
★ N/A
N/A
Revenue
N/A
★ $75,128,000.00
Revenue This Year
$4.87
N/A
Revenue Next Year
$5.02
$21.85
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 160.56
52 Week Low
$5.00
$2.75
52 Week High
$7.11
$13.18

Technical Indicators

Market Signals
Indicator
AQN
ABCL
Relative Strength Index (RSI) 23.23 59.17
Support Level N/A $10.38
Resistance Level $6.06 $12.58
Average True Range (ATR) 0.11 0.56
MACD -0.04 -0.05
Stochastic Oscillator 0.00 62.24

Price Performance

Historical Comparison
AQN
ABCL

About AQN Algonquin Power & Utilities Corp.

Algonquin Power & Utilities Corp is a Canada-based diversified international generation, transmission, and distribution company. The company's operations are organized across two business units: the Regulated Services Group, which owns and operates a portfolio of regulated electric, water distribution, and wastewater collection, and natural gas utility systems and transmission operations in the United States, Canada, Bermuda, and Chile; and the Hydro Group, which consists of hydroelectric-generating facilities located in Canada. It generates the majority of its revenue from the Regulated Services Group segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: